002773.SZ
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 18.78
−0.58%Year over year
Reported trailing growth
- Revenue
- -2.8%
- EBITDA
- —
- EBIT
- -9.2%
- EPS
- -12.3%
- Free cash flow
- -12.0%
- Operating cash flow
- -1.7%
Forward estimates
Based on analyst estimates
- Revenue
- -13.7%
- EBITDA
- -45.1%
- EPS
- -45.5%
Three-year CAGR
- Revenue
- +10.6%
- EBITDA
- +11.3%
- EBIT
- +10.7%
- Net income
- +9.1%
- EPS
- +8.7%
- Free cash flow
- +29.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026